Search for content, post, videos

Biotech Business

Spherotide to the Chinese market
Spherotide to the Chinese market

Xbrane Biopharma and China Resource Pharmaceutical Group Limited have entered into a license agreement which gives CR Pharma exclusive rights to market and sell Spherotide (Triptorelin, a GnRH analogue in

Drug Development Biotech